Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa

NCT03409679 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

41

Enrollment

INDUSTRY

Sponsor class

Stopped Safety data review

Conditions

Pneumonia

Interventions

DRUG: Murepavadin
DRUG: Two anti-pseudomonal antibiotics

Sponsor

Polyphor Ltd.